Tumor-expressed PD-L1 is regulated by multiple mechanisms, including activation of the phosphatidylinositol 3-kinase (PI3K) signaling pathway and TIL-secreted interferon gamma (IFN-γ). Here, IFNG is linked to neoplasm.